Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential sensitivity patterns in small cell lung cancer cell lines: detection and circumvention of resistance to topoisomerase II targeting drugs.

Danish medical bulletin - 1 Nov 1994

Jensen P B

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carcinoma, Small Cell
Share to DNA, Neoplasm
Share to DNA Topoisomerases, Type II

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Evaluation, Preclinical

Share to Drug Resistance, Multiple

Share to Tumor Cells, Cultured

Share to Tumor Stem Cell Assay

Source

Identifiers

PMID: 7859516

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential sensitivity patterns in small cell lung cancer cell lines: detection and circumvention of resistance to topoisomerase II targeting drugs.PMID 7859516Read ↗

Drug resistance in lung cancerSemantic proximity Read ↗

Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.Semantic proximity Read ↗

Determinants of Response to the DNA Topoisomerase II Inhibitors Doxorubicin and Etoposide in Human Lung Cancer Cell LinesSemantic proximity Read ↗

Persistent TOP1 cleavage complexes in drug-tolerant cells drive adaptive resistance to EGFR-targeted therapies in lung cancer.Semantic proximity Read ↗

Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatinSemantic proximity Read ↗

Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinomaSemantic proximity Read ↗

Systematic identification of genomic markers of drug sensitivity in cancer cellsSemantic proximity Read ↗

DNA topoisomerase II mutations and resistance to anti-tumor drugs.Semantic proximity Read ↗

Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Drug sensitivity in cancer cell lines is not tissue-specificSemantic proximity Read ↗

Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteinsSemantic proximity Read ↗

Molecular profiling of lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.